Determination of phenobarbital in human plasma by a specific liquid chromatography method: application to a bioequivalence study
AUTOR(ES)
Dalmora, Sérgio Luiz, Sangoi, Maximiliano da Silva, Nogueira, Daniele Rubert, D'Avila, Felipe Bianchini, Moreno, Ronílson Agnaldo, Sverdloff, Carlos Eduardo, Oliveira, Rogério Antonio de, Borges, Ney Carter
FONTE
Química Nova
DATA DE PUBLICAÇÃO
2010
RESUMO
A liquid chromatography method was developed and validated for the determination of phenobarbital in human plasma using phenytoin as internal standard. The drugs were extracted from plasma by liquid-liquid extraction and separated isocratically on a C12 analytical column, maintained at 35 ºC, with water:acetonitrile:methanol (58.8:15.2:26, v/v/v) as mobile phase, run at a flow rate of 1.2 mL/min with detection at 205 nm. The method was linear in the range of 0.1-4 μg/mL (r²=0.9999) and demonstrated acceptable results for the precision, accuracy and stability studies. The method was successfully applied for the bioequivalence study of two tablet formulations (test and reference) of phenobarbital 100 mg after single oral dose administration to healthy human volunteers.
Documentos Relacionados
- Determination of levodopa in human plasma by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS): application to a bioequivalence study
- Determination of Gemifloxacin in human plasma by high performance liquid chromatography using Ultra Violet detector and its application to a bioequivalence study
- Estimation of rosuvastatin in human plasma by HLPC tandem mass spectroscopic method and its application to bioequivalence study
- Method development and validation for naratriptan determination in human plasma by HPLC with tandem mass spectrometry detection, and its application to bioequivalence study
- Quick and simple LC-MS/MS method for the determination of simvastatin in human plasma: application to pharmacokinetics and bioequivalence studies